JP2007508395A5 - - Google Patents

Download PDF

Info

Publication number
JP2007508395A5
JP2007508395A5 JP2006535619A JP2006535619A JP2007508395A5 JP 2007508395 A5 JP2007508395 A5 JP 2007508395A5 JP 2006535619 A JP2006535619 A JP 2006535619A JP 2006535619 A JP2006535619 A JP 2006535619A JP 2007508395 A5 JP2007508395 A5 JP 2007508395A5
Authority
JP
Japan
Prior art keywords
ethyl
cyclohexanol
phenyl
dihydrochloride
chlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006535619A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007508395A (ja
Filing date
Publication date
Priority claimed from US10/962,971 external-priority patent/US7550485B2/en
Application filed filed Critical
Publication of JP2007508395A publication Critical patent/JP2007508395A/ja
Publication of JP2007508395A5 publication Critical patent/JP2007508395A5/ja
Pending legal-status Critical Current

Links

JP2006535619A 2003-10-14 2004-10-13 血管運動症状を治療するためのモノアミン再取り込み調節剤としての置換n−ピペリジン誘導体 Pending JP2007508395A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US51104203P 2003-10-14 2003-10-14
US56144804P 2004-04-12 2004-04-12
US57002604P 2004-05-11 2004-05-11
US10/962,971 US7550485B2 (en) 2003-10-14 2004-10-12 Substituted N-heterocycle derivatives and methods of their use
PCT/US2004/033732 WO2005037279A1 (en) 2003-10-14 2004-10-13 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms

Publications (2)

Publication Number Publication Date
JP2007508395A JP2007508395A (ja) 2007-04-05
JP2007508395A5 true JP2007508395A5 (enExample) 2007-11-29

Family

ID=34468489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006535619A Pending JP2007508395A (ja) 2003-10-14 2004-10-13 血管運動症状を治療するためのモノアミン再取り込み調節剤としての置換n−ピペリジン誘導体

Country Status (17)

Country Link
US (2) US7550485B2 (enExample)
EP (1) EP1673084B1 (enExample)
JP (1) JP2007508395A (enExample)
KR (1) KR20070026326A (enExample)
AR (1) AR046283A1 (enExample)
AT (1) ATE400273T1 (enExample)
AU (1) AU2004281746A1 (enExample)
BR (1) BRPI0415294A (enExample)
CA (1) CA2540191A1 (enExample)
DE (1) DE602004014955D1 (enExample)
EC (1) ECSP066506A (enExample)
IL (1) IL174472A0 (enExample)
MX (1) MXPA06003880A (enExample)
PA (1) PA8615001A1 (enExample)
PE (1) PE20050440A1 (enExample)
TW (1) TW200526619A (enExample)
WO (1) WO2005037279A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) * 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
JP2008508359A (ja) 2004-08-02 2008-03-21 グラクソ グループ リミテッド 抗菌剤
AU2006321947A1 (en) * 2005-12-05 2007-06-14 Wyeth Process for preparing substituted aryl cycloalkanol derivatives
WO2008057855A2 (en) 2006-11-01 2008-05-15 Bristol-Myers Squibb Company Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity
AR077969A1 (es) * 2009-08-31 2011-10-05 Abbott Healthcare Products Bv Derivados de (tio)morfolina comomoduladores de s1p
SG179120A1 (en) 2009-09-29 2012-05-30 Glaxo Group Ltd Novel compounds
EP2531494A4 (en) 2010-02-02 2014-10-15 Agency Science Tech & Res FUNCTIONALIZED ABSORPTION-RELATED CONNECTIONS AND THEIR USE
TWI522361B (zh) 2010-07-09 2016-02-21 艾伯維公司 作為s1p調節劑的稠合雜環衍生物
TW201206893A (en) 2010-07-09 2012-02-16 Abbott Healthcare Products Bv Bisaryl (thio) morpholine derivatives as S1P modulators
TW201643169A (zh) 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物
US11535632B2 (en) 2019-10-31 2022-12-27 ESCAPE Bio, Inc. Solid forms of an S1P-receptor modulator

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1963458A (en) * 1930-01-22 1934-06-19 George M Holley Carburetor
US1962880A (en) * 1931-06-20 1934-06-12 Schwab Max Electric drive for household sewing machines
US1962897A (en) * 1931-11-03 1934-06-12 Edward J Duffy Printing press
US1963111A (en) * 1932-01-08 1934-06-19 Backes Henry Dispensing attachment for liquid cement containers
US1962899A (en) * 1932-07-30 1934-06-12 Charles S Hagy Sectional portable bowling alley
US1962881A (en) * 1932-11-04 1934-06-12 Connor B Shanley Manhole cover and anchoring means therefor
US1963064A (en) * 1933-03-21 1934-06-19 American Steel & Wire Co Adjustable die-holder
US3454554A (en) 1960-10-14 1969-07-08 Colgate Palmolive Co Aminoalkyliminodibenzyl compounds
CS175831B1 (enExample) 1974-12-17 1977-05-31
IL56369A (en) 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4310524A (en) 1980-04-11 1982-01-12 Richardson-Merrell, Inc. TCA Composition and method for rapid onset antidepressant therapy
PH18686A (en) 1981-05-26 1985-08-29 Merck & Co Inc 1-(3 halo-2-pyridinyl) piperazine
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
CA1280421C (en) 1985-07-02 1991-02-19 Albert A. Carr 1,4-disubstituted piperidinyl derivatives
ZA885824B (en) 1987-08-14 1989-04-26 Merrell Dow Pharma Novel antidepressants
US4826844A (en) 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
AU652759B2 (en) 1990-06-01 1994-09-08 Aventisub Ii Inc. (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol
US5502047A (en) 1993-03-22 1996-03-26 Kavey; Neil B. Treatment for insomnia
CN1494907A (zh) 1996-03-25 2004-05-12 治疗疼痛的药物组合物
HUP0101404A3 (en) 1998-03-02 2002-09-30 Lilly Co Eli Fluoxetine hydrochloride for decreasing hot flashes
HUP0200898A3 (en) 1999-04-06 2005-09-28 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
ES2246488T3 (es) 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC Reboxetina para tratar la migraña.
AU6640800A (en) * 1999-08-11 2001-03-05 Vermeer Manufacturing Company Automated lubricant dispensing system and method for a horizontal directional drilling machine
US6569861B2 (en) * 2000-07-06 2003-05-27 Neurogen Corporation Melanin concentrating hormone receptor ligands
DE60119047D1 (de) 2000-08-31 2006-06-01 Pfizer Phenoxyphenylheterozyklen als Serotonin-Wiederaufnahmehemmer
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
EP2319826A1 (en) 2001-02-12 2011-05-11 Wyeth LLC Succinate salt of O-desmethyl-venlafaxin
US6557831B2 (en) * 2001-03-05 2003-05-06 Erwin Industries, Inc. Fence bracket
JP2004525940A (ja) 2001-03-29 2004-08-26 イーライ・リリー・アンド・カンパニー 火照りの処置のためのデュロキセチン
GB0108046D0 (en) 2001-03-30 2001-05-23 Astrazeneca Ab Chemical compounds
EP1266659A1 (en) 2001-06-11 2002-12-18 Pantarhei Bioscience B.V. Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
WO2003037334A1 (en) 2001-10-31 2003-05-08 Merck & Co., Inc. Method for treating or preventing symptoms of hormonal variation including hot flashes
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
SE0103818D0 (sv) * 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
EP1478356A4 (en) 2002-02-08 2005-03-16 Harvard College THERAPEUTIC COMPOUNDS
CA2479350A1 (en) 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
TW200402289A (en) 2002-05-17 2004-02-16 Wyeth Corp Methods of treating gastrointestinary and genitourinary pain disorders
NZ537521A (en) 2002-08-14 2007-05-31 Pharmacia & Upjohn Co Llc Use of reboxetine for the treatment of hot flashes
US20040180879A1 (en) 2002-10-15 2004-09-16 Deecher Darlene Coleman Novel method of treating vasomotor symptoms
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US20040152710A1 (en) 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms

Similar Documents

Publication Publication Date Title
US7037944B2 (en) Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
AU2001293936B2 (en) Association of the CB1 receptor antagonist and sibutramin, for treating obesity
CN1104892C (zh) 采用神经保护剂治疗耳鸣的方法
JP2006514942A5 (enExample)
JP2010053153A (ja) Cb1受容体拮抗剤の経口用医薬組成物
CN1450895A (zh) 雌激素药物药用组合物
JP2006504793A5 (enExample)
JP2004509857A5 (enExample)
JP2002508364A5 (enExample)
RU97118474A (ru) Новые гетероциклические соединения
JP2004525184A5 (enExample)
CA2531068A1 (en) Substituted arylthiourea derivatives useful as inhibitors of viral replication
RU2003131970A (ru) Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
JP2003516975A5 (enExample)
JP2007508393A5 (enExample)
JP2007509076A5 (enExample)
PE20050440A1 (es) Derivados de n-heterociclo sustituidos para modificar la recaptacion de monoaminas
JP2007508392A5 (enExample)
CN1163471C (zh) 3-羟基-丙胺衍生的神经元重吸收抑制剂
CN1285742A (zh) 用于治疗阿尔茨海默氏型老年性痴呆的活性组分的组合
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence
JP2007508394A5 (enExample)
RU2003131965A (ru) Производные 4-(фенил-(пиперидин-4-ил)-амино)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
RU2006116501A (ru) Замещенные n-производныепиперидина в качестве модуляторов обратного захвата моноамина для лечения вазомоторных симптомов
FR2912057A1 (fr) Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine